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Summary
Experimental animal models are extremely valuable for the study of human diseases, especially those with
underlying genetic components. The exploitation of various animal models, from fruitﬂies to mice, has led to
major advances in our understanding of the etiologies of many diseases, including cancer. Cutaneous malignant
melanoma is a form of cancer for which both environmental insult (i.e., UV) and hereditary predisposition are
major causative factors. Fish melanoma models have been used in studies of both spontaneous and induced
melanoma formation. Genetic hybrids between platyﬁsh and swordtails, different species of the genus
Xiphophorus, have been studied since the 1920s to identify genetic determinants of pigmentation and
melanoma formation. Recently, transgenesis has been used to develop zebraﬁsh and medaka models for mela-
noma research. This review will provide a historical perspective on the use of ﬁsh models in melanoma research,
and an updated summary of current and prospective studies using these unique experimental systems.
Gene-environment interactions and animal
melanoma models
Carcinogenesis is a complex, multistage process driven
by genetic and environmental factors. Melanoma is a
salient example of the complexity of gene-environment
interactions in carcinogenesis. Cutaneous malignant
melanoma (CMM) is a deadly form of cancer which
shows an alarming increase in incidence in the US and
worldwide (Linos et al., 2009). Dissecting apart the
genetic from the environmental elements of its complex
etiology is important to understanding its causes and
reversing this trend. Although it is recognized that sun-
light is the major environmental cause of CMM, it is
also clear that heredity is a very strong predisposing fac-
tor (Bishop et al., 2007; Chin et al., 2006; Rivers, 2004).
For example, there are hereditary conditions such as
familial atypical multiple mole-melanoma (FAMMM) syn-
drome (Bergman et al., 1992) as well as epidemiological
data indicating that melanoma is one of the most famil-
ial cancers (Begg et al., 2004; Chaudru et al., 2004;
Hemminki et al., 2003; Kerber and O’Brien, 2005; Rutter
et al., 2004). Such studies of melanoma formation in
human populations are necessarily retrospective, and
therefore animal melanoma models are invaluable tools
in which genetic and environmental components can be
recognized and experimentally isolated.
Mammalian models are of obvious utility in cancer
research, since they have the advantage of being physi-
ologically most similar to humans, with directly compa-
rable cell lineage and differentiation pathways.
However, in many instances non-mammalian models,
particularly genetic models, have convincingly demon-
strated their value in cancer research (Friend, 1993).
Fish models have been used extensively to study a vari-
ety of tumors, including hematological and liver cancers,
various sarcomas, melanoma and other malignancies
(Amatruda and Patton, 2008; Amatruda et al., 2002;
Bailey et al., 1996; Bunton, 1996; Walter and Kazianis,
2001). Some advantages of ﬁsh models in cancer
research include their high fecundity and often short
breeding cycles to produce large numbers of progeny,
cost efﬁciency, and easy exposure to carcinogens
(Amatruda and Patton, 2008; Stern and Zon, 2003).
More importantly, teleosts span the evolutionary dis-
tance between mammals and lower eukaryotic model
organisms such as Drosophila and C. elegans. In terms
of genomics, ﬁsh offer an enormously diverse range of
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tools including extensive and detailed gene maps and
genome sequences have been developed (Froschauer
et al., 2002; Hubbard et al., 2009; Kazianis et al., 2004b;
Knapik et al., 1998; Schartl et al., 2004; Walter et al.,
2004, 2006). Developmental and other types of mutants
are available in well-characterized ﬁsh lines (Amsterdam
and Hopkins, 2006; Patton and Zon, 2001). Innovative
experimental tools such as morpholinos for gene knock-
down (Nasevicius and Ekker, 2000), sophisticated trans-
genesis (Amsterdam and Hopkins, 2006; Esengil and
Chen, 2008; Kwan et al., 2007), high throughput screen-
ing of mutants (Amsterdam and Hopkins, 2006; Patton
and Zon, 2001) and for the pharmacological effects of
small molecules (Zon and Peterson, 2005) are available.
For all these reasons, ﬁsh models are increasingly being
used in cancer research, not only as an adjunct to mam-
malian models, but in many cases because they accom-
modate the most robust experimental approaches to a
particular scientiﬁc problem.
For melanoma research, a variety of non-rodent mod-
els has been studied including Drosophila (Hanratty and
Ryerse, 1981), swine (Greene et al., 1997; Millikan et al.,
1974), horse (Fleury et al., 2000; Rosengren Pielberg
et al., 2008), and the marsupial Monodelphis domestica
(Ley, 2002). Rodent melanoma models include the
Syrian hamster (Fortner and Allen, 1958), hairless mouse
(Kligman and Elenitsas, 2001) and several transgenic
mouse lines (reviewed in Chin, 2003; Noonan et al.,
2003), which have been used extensively to study UV-
induced melanoma formation. Unlike in humans (and
ﬁsh), murine melanocytes are conﬁned to the hair folli-
cles and not distributed throughout the epidermis, and
mice are very refractory to melanoma induction by UV
except in some transgenic models (Noonan et al., 2003).
The most venerable experimental melanoma model,
Xiphophorus, has been studied for over eight decades
and actually constitutes a collection of genetic models
useful for investigating both spontaneous and induced
melanoma formation (Nairn et al., 2001; Walter and
Kazianis, 2001). Recently, transgenic ﬁsh melanoma
models have been developed in the zebraﬁsh Danio rerio
(Patton et al., 2005) and in medaka, Oryzias latipes
(Schartl et al., 2010). This review will describe the
contributions of ﬁsh melanoma models to our current
understanding of melanoma formation, and prospects
for future research using these unique experimental
organisms.
Xiphophorus melanoma models
Early genetic studies of Xiphophorus melanomas
In the late 1920s, it was observed that genetic hybrids
between certain strains of melanistically pigmented
platyﬁsh (Xiphophorus maculatus) and non-pigmented
swordtails (Xiphophorus helleri) developed spontaneous
melanomas from specialized melanin-containing cells
(macromelanophores) comprising various black pigment
patterns (Gordon, 1927; Haussler, 1928; Kosswig, 1927).
These hybrid melanomas originate from cells within
polymorphic pigment patterns derived from the platyﬁsh
strains, which become phenotypically enhanced in hybrid
progeny, typically showing a large proportion of rela-
tively undifferentiated, actively proliferating melanocytes
(Anders, 1991; Gordon, 1959; Vielkind, 1976; Vielkind
and Vielkind, 1982). Human melanomas also consist of
melanocytes with poorly regulated proliferation (Sauter
and Herlyn, 1998), and both Xiphophorus and human
melanomas exhibit similarities in their histopathologies
(Gimenez-Conti et al., 2001; Grand et al., 1941; Ishikawa
et al., 1975; Sobel et al., 1975; Vielkind and Vielkind,
1970; Vielkind et al., 1971). Transplanted Xiphophorus
melanomas are vascularized and grow in nude mice in a
manner indistinguishable from transplanted human mela-
nomas, while maintaining expression of ﬁsh antigens
(Schartl and Peter, 1988).
Early genetic analysis of melanoma formation in Xipho-
phorus hybrids was aided by the fact that pigment pat-
tern-determining loci are sex-linked (Gordon, 1931).
Another characteristic that permitted the application of
classical, recombination genetics in early studies was
that F1 hybrids are fertile, allowing the generation of
interspecies backcross hybrids in genetic crossing
schemes in which platyﬁsh chromosomes were replaced
by corresponding chromosomes from the swordtail
species, used as the recurring backcross parent (Atz,
1962; Gordon, 1958; Kallman, 1970). Results from these
studies, focused largely on pigmentation, were inter-
preted as genetic ‘modiﬁcation’ in hybrids of the effects
of the sex-linked platyﬁsh-derived pigmentation locus by
genes in the swordtail genome. It was speculated that
the modiﬁer genes could be acting either as ‘intensiﬁers’
contributed by the swordtail or ‘suppressors’ from the
platyﬁsh that were introduced by the initial hybridization,
but then eliminated by backcrossing (as discussed in
Schartl, 1995). To explain melanoma formation speciﬁ-
cally in Xiphophorus backcross hybrids, Breider (1952)
hypothesized that inhibitory genes from the platyﬁsh
suppress the expression of pigmentation in a species-
speciﬁc manner, and their loss during backcrossing
promotes melanoma formation in backcross hybrids.
This interpretation represents an early articulation of the
tumor suppressor gene concept, and was formalized for
the Xiphophorus hybrid melanoma almost 25 yr later
(Ahuja and Anders, 1976) based on extensive studies of
a particular Xiphophorus hybrid melanoma model
(Anders, 1967, 1991) which is represented in Figure 1.
In this genetic cross, the platyﬁsh Xiphophorus macul-
atus is hybridized to the swordtail Xiphophorus helleri to
generate F1 hybrids. Backcrossing F1 progeny to the
X. helleri parental species generates ﬁrst-generation
backcross (BC1) hybrids. Although X. maculatus and
X. helleri do not interbreed in natural conditions, artiﬁcial
insemination can be used to produce F1 hybrids (Clark,
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hybrids and the X. helleri recurrent backcross parent in
closed colony matings. Poeciliids such as Xiphophorus
are live-bearers, and inseminated females can store
sperm for months, producing multiple broods in series
of 30-day gestations. Figure 1 shows the basic ele-
ments of this crossing scheme which leads to BC1
hybrids with melanoma. The sex-linked melanistic
pigmentation pattern ‘spotted dorsal’ (Sd) is exhibited
as discrete, punctate black spots on the dorsal ﬁns of
X. maculatus individuals; the strains of X. helleri com-
monly used in this cross (Sarabia and Lancetilla) do not
exhibit this pigmentation pattern and do not possess
the specialized macromelanophores from which it
originates. For simplicity, ‘Sd’ is used in the ﬁgures to
represent the sex-linked genetic locus for the spotted
dorsal pigment pattern. However, it should be noted
that pigmentation is a complex trait involving not only
the presence of macromelanophores, but their differen-
tiation, migration, and extent of proliferation. The nota-
tion Mdl, for macromelanophore-determining locus, has
been proposed to designate the genetic loci which
specify the various sex-linked macromelanophore pig-
mentation patterns observed in Xiphophorus (Wellbrock
et al., 2002). As discussed below, the oncogenic Xmrk
gene is associated with speciﬁc Mdl loci, but neither
the pigment pattern designation (e.g., Sd) nor Xmrk
should be considered as synonymous with a Mdl;
rather, Sd and other pigmentation pattern-determining
loci should be considered as alleles of Mdl. Historically,
the notations Tu and M have also been used in this
context (Anders, 1991; Kallman, 1975).
As represented in Figure 1(A), the F1 hybrid from
crossing Sd-bearing X. maculatus to X. helleri expresses
an enhanced pigmentation pattern on the dorsal ﬁn.
There is extensive melanocytic hyperplasia, or melano-
sis, reﬂecting greater proliferation of macromelano-
phores. Examination of cells from the enhanced
pigment pattern shows altered cell morphology with a
larger proportion of poorly differentiated cells, as well as
more actively dividing cells than seen in pigment pattern
cells from the X. maculatus parental strain (Ahuja et al.,
1980; Siciliano et al., 1976; Vielkind, 1976; Vielkind and
Vielkind, 1970); tyrosinase activity is also elevated (Viel-
kind and Vielkind, 1982). Backcrossing to the X. helleri
parental strain produces BC1 progeny of which approxi-
mately half are non-pigmented (lower right in Figure 1A).
Of the remaining half, there is roughly a 1:1 ratio of BC1
A
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Figure 1. Genetics of the Gordon-Kosswig spontaneous melanoma model. (A) Hybridization of the platyﬁsh X. maculatus, exhibiting the
macromelanophore spotted dorsal (Sd) pigment pattern, to the swordtail X. helleri generates F1 hybrids with an enhanced Sd pigment pattern
on the dorsal ﬁn. Backcrossing F1 hybrids to the X. helleri swordtail species generates ﬁrst generation backcross hybrids (BC1 hybrids) with
three phenotypes, as shown at the bottom of panel A. Approximately one-half of the BC1 hybrids are non-macromelanophore pigmented ﬁsh
exhibiting no melanistic pigmentation (ﬁsh shown at lower right of panel A); these hybrids have not inherited the sex-linked Sd-Mdl allele
(designated in the ﬁgure as Sd) from the original platyﬁsh parent and therefore are not susceptible to melanoma. Of the remaining
approximately one-half of BC1 hybrids, half of these ( 25% of total BC1 progeny) are heavily pigmented and develop invasive, exophytic,
nodular malignant melanoma (lower left individual in panel A) and the other half ( 25% of BC1 progeny) show enhanced Sd pigmentation
resembling the F1 hybrid phenotype, but only rarely develop melanoma late in life. (B) Hypothetical two-gene inheritance model explaining the
apparently Mendelian inheritance of BC1 phenotypes. In this model, R is a platyﬁsh gene that regulates the expression of the Xmrk oncogene
associated with the Sd-Mdl allele, and its total loss in heavily pigmented BC1 hybrids that develop melanoma explains the melanoma
susceptibility of these hybrids. Heterozygosity for R in lightly pigmented BC1 hybrids results in some regulation of Xmrk and inhibits
melanoma formation. (C) Alternative two-gene inheritance model. In this model, the autosomal locus Diff regulates melanoma susceptibility
but is not restricted to the platyﬁsh parent, instead existing as alleles in Xiphophorus spp. populations. Mendelian inheritance of melanoma
susceptibility in pigmented BC1 hybrids is explained by homozygosity versus heterozygosity for the X. helleri Diff allele. These inheritance
models as applied to different Xiphophorus crossing schemes are discussed in the text.
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F1 hybrid, and BC1 hybrids with extremely enhanced
pigment patterns that may not be restricted to the dor-
sal ﬁn; these heavily pigmented hybrids, about 25% of
total backcross progeny, spontaneously develop exophy-
tic, nodular, invasive melanomas. The apparently Men-
delian segregation of these phenotypes is consistent
with a two-gene inheritance model involving a sex-linked
and an autosomal gene locus, two different interpreta-
tions of which are shown in Figure 1(B, C).
In both these inheritance models, it is assumed that
the complex, sex-linked Mdl locus specifying the spot-
ted dorsal pattern (Sd) is absent in the swordtail parent,
X. helleri. In the model of Figure 1(B), the autosomal
gene is designated as R for ‘regulator’ or ‘repression’
gene (Ahuja and Anders, 1976; Anders, 1967; Schartl,
1995). In this case, there are two copies of R in the
highly inbred X. maculatus parental strain, resulting in
tight regulation of the pigment pattern, with controlled
proliferation and a large proportion of terminally differen-
tiated macromelanophores. Hybridization to the inbred
X. helleri parental strain, with no R loci, results in F1
hybrids heterozygous at every genetic locus; inheriting
only one copy of R leads to some loss of regulation of
the pigment pattern, resulting in Sd enhancement,
increased proliferation, and melanosis. (This phenotype
is often referred to as ‘benign melanoma,’ but we prefer
‘melanosis’ or ‘melanocytic hyperplasia’). Backcrossing
F1 hybrids to the X. helleri strain generates progeny in
which there is replacement of X. maculatus genes in F1
individuals based on random assortment in meiosis.
These BC1 progeny have pigmentation phenotypes
deﬁned by the inheritance of Sd and R, as shown in
Figure 1(B). BC1 hybrids that inherit Sd are pigmented,
and whether or not there is some regulation of the pig-
ment pattern (i.e., in pigmented BC1 hybrids that inherit
R), or complete loss of regulation (in pigmented BC1
hybrids that do not inherit R) determines if an individual
BC1 hybrid resembles the F1 phenotype or exhibits
severe melanosis and is prone to developing spontane-
ous, primary malignant melanoma, respectively. This
genetic model obviously lends itself to the interpretation
that a gene associated with the complex Sd-Mdl allele
behaves as a dominant oncogene, and that R is a classi-
cal, recessive tumor suppressor (Ahuja and Anders,
1976; Anders, 1991; Schartl, 1995).
The inheritance model represented in Figure 1(C)
does not assume that the autosomal gene apparently
regulating melanoma susceptibility is present only in the
X. maculatus parent. The notation Diff is derived from
studies of macromelanophore differentiation in Xipho-
phorus species and hybrids (Ahuja et al., 1980; Vielkind,
1976; Vielkind and Vielkind, 1982). From results of these
studies, the autosomal locus Diff was proposed to
regulate macromelanophore differentiation, modifying
pigmentation phenotype to result in either its intensiﬁca-
tion or suppression in genetic hybrids. In this model,
Sd-inheriting pigmented BC1 hybrids fall into one of two
phenotypic categories depending on whether they are
homozygous for the X. helleri Diff allele, or heterozy-
gous, as represented in Figure 1(C). In the crossing
scheme shown, pigmented BC1 X. helleri Diff homozyg-
otes exhibit heavy melanization and are susceptible to
spontaneous melanoma (lower left individual in
Figure 1C). This genetic model accommodates some
early genetic observations in Xiphophorus, primarily
studies of the inheritance of pigmentation, in which so-
called ‘modiﬁers’ or ‘unlinked regulators’ present in the
X. helleri genome were proposed to exert some deter-
minative inﬂuence on the extent of pigmentation pat-
terns and the degree of differentiated pigment cell types
in hybrids (Atz, 1962; Gordon, 1958; Kallman, 1970; Zan-
der, 1969). There is evidence supporting each of these
inheritance models, as discussed in following sections.
Molecular and biochemical characterization of the
sex-linked Xmrk oncogene
Early molecular studies were aimed at identifying the
sex-linked oncogene, then called Tu (for ‘tumor’), associ-
ated with the Sd pigmentation pattern-determining locus
in X. maculatus. The initial focus was on receptor tyro-
sine kinases (RTKs), since high levels of expression of
SRC, FYN, YES and a Rous sarcoma virus-related kinase
were observed in Xiphophorus hybrid melanomas
(Barnekow et al., 1982; Hannig et al., 1991; Schartl et al.,
1982, 1985). Co-segregation of an epidermal growth
factor receptor (EGFR)-related restriction fragment length
polymorphism with Tu was reported in 1988 (Adam
et al., 1988), and Schartl and co-workers subsequently
isolated a novel receptor tyrosine kinase sequence
related to EGFR which satisﬁed the genetic criteria for
Tu, naming it Xmrk for Xiphophorus melanoma receptor
kinase (Wittbrodt et al., 1989). In addition to its isolation
by positional cloning, Xmrk was conﬁrmed to be the Tu
oncogene by the demonstration that deletion or disrup-
tion of this gene abrogated the potential to cause mela-
nomas in hybrid ﬁsh (Schartl et al., 1999). Xmrk was
observed to be overexpressed in melanomas arising in
Xiphophorus BC1 hybrids (Adam et al., 1991) and also in
melanomas occurring in certain pigmented, non-hybrid
ﬁsh (Kazianis and Borowsky, 1995; Schartl et al., 1995).
A very recent publication (Schartl et al., 2010) demon-
strates that a Xmrk transgene in medaka is capable of
inducing melanomas; this study is discussed in some
detail later in this review. All these observations support
the conclusion that Xmrk can function as a dominant,
melanoma-inducing oncogene.
Initial molecular analysis of the Tu region of the sex
chromosome revealed that Xmrk had resulted from a
gene duplication and a subsequent rearrangement that
fused an adventitiously acquired promoter to the mela-
noma-inducing copy of Xmrk (Adam et al., 1992). These
ﬁndings resulted in the designations ONC-Xmrk (for
the oncogenic copy) and INV-Xmrk (for the original,
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EGFR-related gene (other workers have referred to
these duplicated genes as Xmrk-2 and Xmrk-1, respec-
tively; see Kazianis et al., 2000; Woolcock et al., 1994).
However, subsequent work by Schartl and colleagues
(Gomez et al., 2004) established that INV-Xmrk is an
ortholog of EGFR, which is genomically duplicated in
Xiphophorus, and the designations egfrb and Xmrk are
now preferred for the original and oncogenic sex-linked
gene copies. Recently, bacterial artiﬁcial chromosome
(BAC) contigs have been assembled for the subtelo-
meric sex-determining region of X. maculatus sex chro-
mosomes (Schultheis et al., 2006), revealing that the
sex determination region in X. maculatus is unstable
and subject to frequent duplications, deletions, and
transpositions. As suggested by these authors, this
instability may help to explain the highly polymorphic
nature of macromelanophore pigment patterns and
melanoma phenotypes, as well as other sex-linked poly-
morphic traits in Xiphophorus such as age at onset of
sexual maturity.
Molecular analysis of Xmrk and egfrb gene structure
and expression has shown that both loci are closely
linked to the Mdl locus, mapping within 0.6 cM on the
X. maculatus X chromosome, physically located ‡1M b
apart with Xmrk closer to the telomere (Gutbrod and
Schartl, 1999; Schultheis et al., 2006). Each gene is
about 23 kb in size, with exon-intron structures very
similar to the receptor tyrosine kinases found in higher
vertebrates (Gutbrod and Schartl, 1999). Transcript sizes
are polymorphic, with egfrb producing a 5.8 kb tran-
script and Xmrk producing a 4.7 kb transcript (Adam
et al., 1991). The egfrb gene is ubiquitously expressed
at low levels (Dimitrijevic et al., 1998) and is develop-
mentally modulated during embryogenesis and organo-
genesis (Wittbrodt et al., 1989). The Xmrk transcript, by
contrast, is not detected in any tissues except pigment
cells in the pigment patterns giving rise to melanomas
in hybrids, and in the melanomas, being highly
expressed in both contexts (Dimitrijevic et al., 1998;
Kazianis et al., 2000; Wellbrock et al., 1998; Woolcock
et al., 1994). Molecular characterization of the regions
upstream from both genes has shown that the promot-
ers are completely different from each other. The egfrb
promoter has features of a housekeeping gene, consis-
tent with its observed expression patterns. The Xmrk
promoter is apparently derived from a unique D (for
‘donor’) locus on the sex chromosome, which is ampli-
ﬁed and distributed throughout the Xiphophorus
genome. The D locus is associated with a zinc ﬁnger
gene and a gene of unknown function in the ampliﬁed
regions (Fornzler et al., 1996; Nanda et al., 1996; Schartl
et al., 1994). A recombination event involving this ampli-
ﬁed structure is hypothesized to have created a novel
promoter for Xmrk (Fornzler et al., 1996; Nanda et al.,
1996). Various transcription factor motifs have been
identiﬁed in the Xmrk promoter, including a GC box
(Baudler et al., 1997) and a CpG island. The CpG island is
hypermethylated in non-hybrid ﬁsh but hypomethylated
in melanized tissues from hybrids and in a melanoma-
derived ﬁsh cell line, which may contribute to Xmrk
expression characteristics during melanomagenesis
(Altschmied et al., 1997).
As noted above, Xmrk is highly expressed in pigment
cells, and signiﬁcantly more Xmrk overexpression in
melanomas is a critical feature of malignant transforma-
tion by this oncogene. However, comparing the Xmrk
oncoprotein to its Egfrb progenitor also reveals amino
acid residue differences that contribute to its oncogenic-
ity as well as speciﬁc mutations in Xmrk that lead to its
dimerization and constitutive activation in melanoma
cells (Dimitrijevic et al., 1998; Meierjohann et al., 2006a;
Winnemoeller et al., 2005). A large body of biochemical
studies from Schartl’s group, using ﬁsh and cell culture
models, has characterized cellular responses to Xmrk
activation (reviewed in Meierjohann and Schartl, 2006).
Xmrk-initiated signaling mimics binding of a growth
factor ligand to transmembrane receptor (Gomez et al.,
2001), and activates multiple downstream signaling
cascades through the RAS-RAF-MEK-ERK (MAPK) and
PI3K-AKT pathways, as well as activating STAT5, result-
ing in robust proliferation signaling and survival (anti-
apoptotic) responses (Baudler et al., 1999; Hassel et al.,
2008; Morcinek et al., 2002; Wellbrock and Schartl,
1999; Wellbrock et al., 1995, 1999). Figure 2 represents
a simpliﬁed model for some of the downstream effects
of Xmrk activation in melanoma cells; a more complete
and detailed model is provided in Meierjohann and
Schartl (2006). In addition to initiating the signaling
cascades illustrated in Figure 2, Xmrk has been shown
to induce motility in melanocytes through its interaction
with FYN to stimulate the focal adhesion kinase, which
modulates focal adhesions (Meierjohann et al., 2006b).
There are also additional effects downstream from
phosphorylated MAPK that facilitate survival responses
and inhibit melanocyte differentiation (Meierjohann and
Schartl, 2006). The many physiological responses down-
stream from Xmrk in pigment cells and melanomas
derived from them in Xiphophorus are thus consistent
with robust, cell type-speciﬁc proliferation and anti-
apoptosis, characteristic of these tumors.
Xmrk is a potent oncogene, and yet is maintained in
wild populations, leading to speculation that it has been
retained during evolution by conferring some selective
advantage(s). One hypothesis is that Xmrk could be act-
ing as a speciation gene, shielding a species from
hybridization by being deleterious in genetic hybrids;
however, there are a number of arguments against this
notion as applied to Xmrk (Schartl, 2008). Nonetheless,
a recent, intriguing study of mating behavior in Xipho-
phorus cortezi showed that females prefer males with
enhanced spotted caudal (Sc) pigmentation patterns
(Fernandez and Morris, 2008). All Xiphophorus species
with Xmrk exhibit a macromelanophore pigment pattern
Patton et al.
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was conﬁrmed to be associated with Xmrk in this study,
and it was concluded that sexual selection was respon-
sible for maintaining the Xmrk oncogene in X. cortezi
populations. For the individual male, the deleterious
effect of Sc enhancement, increased melanoma risk, is
counterbalanced by increased male acquisition of
females. One of the wild populations studied had a
higher frequency of Sc among females, mitigating the
mating preference displayed in the other populations
and suggesting that sexual selection for Sc was fre-
quency dependent. As the authors point out, these
results are relevant to the evolutionary origin of cancer,
since recent ﬁndings have demonstrated that several
types of cancer are under positive selection (Crespi and
Summers, 2006). The Xiphophorus hybrid melanoma
models thus offer an excellent experimental avenue for
further investigation of the molecular genetics under-
lying this observation.
Genetic characterization of the autosomal
melanoma susceptibility locus
Although Xmrk behaves as a frank oncogene in many
contexts, including in some non-hybrid Xiphophorus
species with differing macromelanophore pigment
patterns (Fernandez and Morris, 2008; Kazianis and
Borowsky, 1995; Schartl et al., 1995), an additional,
autosomal gene is required to explain melanoma forma-
tion in most Xiphophorus hybrid models. Early efforts
aimed at identifying this gene were focused on gene
mapping approaches. Because interspecies genetic
hybrids are extremely polymorphic, separation of
proteins based on charge differences by isozyme elec-
trophoresis in starch gels (which allows activity staining)
provides a powerful genotyping methodology that
enables mapping of gene linkages by analyzing genetic
recombination in BC1 hybrids (Morizot et al., 2001).
Construction of a genetic linkage map for Xiphophorus
was initiated using this approach in the 1970s, and a
locus called Mel Sev (for ‘melanoma severity’) was
linked to esterase-1 in Xiphophorus by Siciliano et al.
(1976). This linkage assignment for the Diff autosomal
melanoma susceptibility locus was conﬁrmed by later
studies (Ahuja et al., 1980; Morizot and Siciliano, 1983).
The development and application of DNA polymor-
phisms, including microsatellites, for linkage mapping in
Xiphophorus has resulted in more robust gene maps
and a more detailed, ﬁner scale map of the LG V region
encompassing the Diff locus (Kazianis et al., 2004b;
Walter et al., 2004).
The search for Diff candidate genes initially relied on
cloning and mapping of the Xiphophorus homologs of
likely tumor suppressors. As a result, p53, RB and
CDKN2 homologs, as well as other genes involved in
tumorigenesis, were isolated from Xiphophorus using
various cloning strategies and mapped (Butler et al.,
2007; Kazianis et al., 1998a; Morizot et al., 1998; Nairn
et al., 1996a). However, mapping of these sequences
did not show linkage to any LG V markers until genetic
analysis of a UV-inducible Xiphophorus melanoma model
(described in the next sections) revealed signiﬁcant link-
age of the heavily melanized pigmentation phenotype
and melanoma susceptibility to a CDKN2-related seq-
uence that mapped to LG V (Nairn et al., 1996b). This
gene, named CDKN2X, localized to the region of LG V
expected to contain the Diff locus, and was also an
attractive candidate for Diff because of the well estab-
lished association of CDKN2A mutations with suscepti-
bility to melanoma in humans (Chin et al., 2006).
However, subsequent studies (Kazianis et al., 1999,
2000) revealed that CDKN2X was hypomethylated and
overexpressed in melanized skin and melanomas, an
unexpected characteristic based on the role of CDKN2A
in human melanoma as currently understood (Ruas and
Peters, 1998), although CDKN2A is overexpressed in
some other human cancers. For example, CDKN2A is
overexpressed in an experimental mouse bladder carci-
noma (Asamoto et al., 1998), in some human breast
cancers (Emig et al., 1998), and in ovarian carcinomas,
in which overexpression may be an early event in
tumorigenesis (Shigemasa et al., 1997).
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Figure 2. Simple model for activation of downstream proliferation
and pro-survival pathways by Xmrk. The Xmrk oncogene is
constitutively activated in melanocytes constituting Xiphophorus
macromelanophore pigment patterns. Signaling through STAT5 and
PI3K pathways evokes both proliferation and anti-apoptosis, as
shown at the left of the ﬁgure. Xmrk also orchestrates downstream
RTK signaling mediated by FYN and the RAS-RAF-MEK-ERK cascade
leading to phosphorylation of MAP kinase and its activation,
providing further proliferation stimulus as shown at the right.
Activation of Xmrk has multiple other downstream effects, as
extensively discussed in Meierjohann and Schartl (2006).
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from X. maculatus and X. helleri revealed only two
amino acid differences (Kazianis et al., 1999; Nairn
et al., 2001), which are not predicted to affect their
activities as CDK inhibitors based on functional studies
of mammalian CDKN2 proteins. A noteworthy structural
difference between CDKN2X and mammalian CDKN2A
genes is the absence of the alternative reading frame
encoding the ARF protein in CDKN2A. In addition, there
is no evidence in Xiphophorus of the CDKN2A⁄CDKN2B
gene duplication existing in mammals. In Fugu, a Tetra-
odontiform ﬁsh with a compact genome, it has been
established that a corresponding gene called INK4AB
also is not associated with an ARF or gene duplication,
and that only a single additional paralog (INK4D) likely
exists in the Fugu genome (Gilley and Fried, 2001). A
CDKN2D gene was cloned from Xiphophorus and analy-
sis of its structure in comparison to Fugu INK4D, Xipho-
phorus CDKN2X and the mammalian CDKN2 family
revealed that the same was true, leading to re-naming
the CDKN2X gene CDKN2AB (Kazianis et al., 2004a).
Thus, in both Tetraodontiform and Cyprinodontiform
ﬁshes this gene appears to be ancestral to both
CDKN2A (INK4A) and CDKN2B (INK4B), and both dupli-
cation and association with ARF of this ancestral gene
occurred after the evolutionary divergence of the lineage
leading to mammals from ﬁsh.
Although the p13 (13 kDa) proteins encoded by the
X. maculatus and X. helleri CDKN2AB alleles are almost
identical, numerous sequence differences are evident in
the promoter regions of these two alleles, leading to
speculation that differences in transcriptional regulation
could be involved in expression of the melanoma pheno-
type in BC1 hybrids (Butler et al., 2007; Nairn et al.,
2001). In rare CDKN2AB heterozygous BC1 hybrid mela-
nomas there is signiﬁcant CDKN2AB overexpression, as
also seen in homozygous BC1 hybrid melanomas; how-
ever, allele-speciﬁc RT-PCR analysis of gene expression
shows signiﬁcant differential overexpression of the
X. maculatus CDKN2AB allele relative to the X. helleri
allele (>11-fold) in melanomas from these heterozygotes
(Kazianis et al., 2000). A model for the possible role of
CDKN2AB in melanoma formation was proposed (Nairn
et al., 2001) in which the differential expression of the
X. maculatus and X. helleri alleles in Xmrk-inheriting BC1
hybrids results in dysregulation of the G1⁄S checkpoint
and loss of control of melanocytic proliferation, leading
to melanoma formation (Figure 3). In this model, the
pigmented X. maculatus parental strain robustly
expresses CDKN2AB (heavy arrow) mitigating the
effects of Xmrk overexpression and resulting in con-
trolled melanocytic proliferation and small, discrete pig-
ment spots. By contrast, in F1 hybrids and the fraction
of BC1 hybrids that are CDKNAB heterozygotes, there is
some loss of regulation of Xmrk activity due to less
overall CDKNAB expression from the two different
alleles (postulating that the X. helleri allele is a weak
expressor, thin arrow) resulting in pigment pattern
enhancement and benign hyperplasia. According to this
model, in the BC1 hybrids that are homozygous for the
X. helleri CDKN2AB allele, there is virtually complete
loss of control of melanocyte proliferation in the macro-
melanophore pigment patterns and melanomas are
formed.
Xmrk activates the RAS-RAF-MEK-ERK (MAPK) path-
way, resulting in strong proliferation signaling (Figure 2).
In human melanoma development, benign nevi often
harbor BRAF mutations (e.g., V600E), which convert it
into an active oncogene. Paradoxically, such nevi persist
in a growth arrested state, rarely progressing to
melanomas (Bennett, 2003). However, this can be at
least partly explained by the fact that oncogenic BRAF
induces CDKN2A expression, promoting oncogene-driven
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Figure 3. Hypothetical model for the possible role of CDKN2AB in
regulating proliferation at the G1⁄S checkpoint. In the generalized
model depicted, hyperphosphorylation of the retinoblastoma protein
(pRb) releases transcription factor E2F and its dimerization partner
(DP), which represent members of a family of transcription factors
that upregulate many genes necessary for DNA synthesis. This
step is controlled by the cyclin-dependent kinase inhibitor (CDKN2)
family in mammalian cells, which bind to CDK4 and CDK6 and
prevents their binding to Cyclin Ds (or E); this step may be similarly
regulated by CDKN2AB in Xiphophorus melanocytes. In a situation
where persistent and strong proliferation signals are generated,
(shown at top left) originating from overexpression of Xmrk in
melanoma cells through tyrosine kinase-mediated signaling
pathways, there may be compensation by CDKN2AB
overexpression (top right). For a UVB inducible melanoma model
(shown in Figure 4D), Kazianis et al. (1999) have shown that in
CDKN2AB heterozygotes with melanomas, there is marked
differential expression of this proliferation inhibitor in melanoma
tissue, with the X. maculatus CDKN2AB allele overexpressed
>11-fold compared to the X. helleri allele, suggesting the possibility
that greater expression of X. maculatus CDKN2AB (thick ﬁlled
arrow, upper right) relative to the expression levels capable from
X. helleri CDKN2AB (thin ﬁlled arrow, upper right) might partially
compensate in heterozygotes for the strong proliferation signals
driven by Xmrk overexpression. Used with permission.
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(Michaloglou et al., 2005). In human melanoma develop-
ment, transformation from this benign state of cell senes-
cence to malignancy may require additional genetic or
epigenetic changes which enable BRAF to exert its
oncogenic effect. As suggested by Butler et al. (2007),
Xiphophorus hybrid melanomas may represent a some-
what parallel situation in which regulation of CDKN2AB
expression in melanocytes in pigment patterns deter-
mines whether their proliferation is controlled or uncon-
trolled. Rather than additional mutational changes, the
substitution of different CDKN2AB alleles with differing
expression characteristics in hybrid genetic backgrounds
may inﬂuence the degree to which the G1⁄S check-
point can be ‘balanced’ through its maintenance by
cyclin-dependent regulation of Rb phosphorylation, regu-
lated in turn by CDKN2AB (Figure 3). Since Xmrk is such
a potent oncogene, in Xiphophorus hybrid melanomas
mutational changes in other genes may not be necessary
for melanoma development once this equilibrium is
disrupted.
To further investigate differences in transcriptional
regulation of the X. maculatus and X. helleri CDKN2AB
alleles, reporter genes were constructed containing
upstream regions of these alleles and expression
analysis was performed in Xiphophorus cell lines of
melanoma (PSM cells, Wakamatsu, 1981) and non-
melanoma (A2 cells, Kuhn et al., 1979) origin; these two
Xiphophorus cell lines have been extensively used by
Schartl and colleagues to study Xmrk biochemistry
(Wellbrock et al., 2002). Results of deletion analysis
suggested that there is a series of positive- and nega-
tive-acting elements present in the X. maculatus
CDKN2AB promoter which are absent or less active in
the X. helleri promoter (A. Butler, M. Friedersdorf,
D. Trono, P. de Forest, J. Plummer, J. Rahn, R.S.N, sub-
mitted). Of particular interest, experimental results from
this study showed that a perfect Sp consensus
sequence in the untranslated region (UTR) of X. helleri
CDKN2AB is mutated in X. maculatus such that it has
lost its responsiveness to Sp3, which is a negative
transcriptional regulator abundant in ﬁsh cells. It is
possible that the mutated Sp consensus sequence in
the X. maculatus CDKN2AB UTR may have been
selected to lose its response to Sp3 in co-evolution with
Xmrk, resulting in loss of negative transcriptional regula-
tion of CDKN2AB in this pigmented species and more
robust expression. This might contribute to explaining
how the strong proliferative effects of Xmrk are
mitigated in Xiphophorus species that exhibit macromel-
anophore pigment patterns, and become uncontrolled in
some hybrids. Further studies of a number of different
species and different Xiphophorus melanoma models
will be required to elucidate this issue.
It must be noted that the genetic evidence supporting
CDKN2AB as a candidate gene for Diff is stronger that
the functional evidence. A study by Kazianis et al.
(1998b) used over 1100 BC1 hybrid ﬁsh from four differ-
ent crossing schemes which involved both Sd and Sp
pigment patterns to show an robust association of
CDKN2AB with Diff (as deﬁned by zygosity-controlled
pigmentation phenotype). In this study, quantitative trait
linkage (QTL) analysis revealed a signiﬁcant likelihood
ratio statistic (>10) generated from a whole-genome per-
mutation test. However, the fact remains that CDKN2AB
is overexpressed in Xiphophorus melanomas, which is
not consistent with the behavior predicted from the role
of CDKN2A in human melanomagenesis (Ruas and
Peters, 1998), or the function of a classical tumor
suppressor gene, as illustrated for R in Figure 1(B). This
oncogene-tumor suppressor gene model, in which R is
exclusively a platyﬁsh gene and acts upstream to regu-
late Xmrk expression or activity, and loss of both copies
of R results in melanoma-susceptible BC1 hybrids, is
ascendant in current thinking about the molecular
genetic basis of spontaneous melanoma formation in the
‘classical’ Gordon-Kosswig Xiphophorus model shown in
Figure 1(A) (Meierjohann and Schartl, 2006). However,
the inheritance model represented in Figure 1(C), in
which Diff as the autosomal determinant of melanoma
susceptibility exists as alleles in different Xiphophorus
species is conceptually broader, and can explain the
inheritance of pigmentation and melanoma susceptibility
phenotypes in the Gordon-Kosswig cross equally as well
as the model of Figure 1(B). As discussed in the next
section, it also can explain other hybrid phenotypes
showing suppression or differing degrees of pigment
pattern enhancement and different susceptibilities to
melanoma formation, as observed in Xiphophorus BC1
hybrids generated from different genetic crossing
schemes.
Inducible melanoma formation and
photocarcinogenesis in Xiphophorus hybrid
melanoma models
The preceding discussion has largely been concerned
with the roles of Xmrk and Diff in the so-called ‘classi-
cal’ or Gordon-Kosswig Xiphophorus hybrid melanoma
model shown in Figure 1. However, as discussed in this
section, numerous genetic crossing schemes have been
developed using different Xiphophorus species, primarily
for purposes of studying the inheritance of other pig-
mentation patterns and sex-linked characteristics such
as fecundity and age at onset of sexual maturity. Some
of these crosses also provide additional melanoma
models. BC1 progeny from some crosses exhibit lower
spontaneous melanoma frequencies than those from
the classical Xiphophorus hybrid melanoma model. One
genetic cross, in fact, shows complete suppression of
pigmentation in BC1 hybrids that inherit the Sd-Mdl
allele from the same X. maculatus parental strain used
in the Gordon-Kosswig cross (Figure 4B). Also shown in
Figure 4, BC1 hybrids from different crosses can exhibit
different degrees of pigment pattern enhancement,
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on what species of non-melanin pigmented Xiphophorus
is used as the recurrent backcross parent.
For example, panels A–C of Figure 4 represent three
different genetic crosses all of which use the platyﬁsh
X. maculatus strain Jp 163 A as the pigmented parent.
However, three different Xiphophorus species are used
as the recurrent backcross parent. Panel A shows the
Gordon-Kosswig cross also shown in Figure 1, in which
the Sd-Mdl allele (designated as ‘Sd’) conferring the
spotted dorsal pattern is enhanced in F1 hybrids and
which generates spontaneous melanoma-susceptible
BC1 hybrids after backcrossing to the swordtail parent
X. helleri. However, if the platyﬁsh X. couchianus is
substituted for X. helleri in this crossing scheme (panel
B), there is complete suppression of the Sd-Mdl allele,
and neither F1 nor BC1 hybrids are pigmented. If the
same crossing scheme is used, but the platyﬁsh
X. andersi is substituted as the recurrent backcross
parent (panel C) there is enhancement of Sd in F1
hybrids and a wide range of pigmented phenotypes
in BC1 hybrids, from very light (resembling the
X. maculatus parent) to very heavy. Crosses repre-
sented in panels D–F show the effects on pigmentation
phenotype of substituting X. maculatus strain Jp 163 B
containing the spotted side Sp-Mdl allele (‘Sp’) for
A
B
C
D
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F
Figure 4. Crossing schemes for generating backcross hybrids. (A) Gordon-Kosswig spontaneous melanoma model (also shown in Figure 1):
In this cross, X. maculatus Jp 163 A, carrying the spotted dorsal (Sd) pigment pattern locus, is mated to X. helleri, which is wild-type (+⁄+) for
this macromelanophore pigment pattern locus. F1 hybrids are then crossed back to X. helleri, and the ﬁrst backcross generation exhibits
heavy (Sd⁄+) and light (+⁄+) pigmentation phenotypes. In this crossing scheme, segregation of the Diff locus determines heavy and light
pigmentation classes in the ﬁrst backcross generation of the pigmented backcross progeny (i.e. the one-half of total backcross progeny
inheriting Sd from the X. maculatus Jp 163 A parent) the heavily pigmented backcross hybrids (lower left) are homozygous for the X. helleri
Diff locus, whereas the lightly pigmented hybrids (second from lower left) are heterozygous for Diff, as is the F1 hybrid. Melanomas develop
spontaneously in the homozygous, heavily pigmented backcross hybrids; (B) Spotted dorsal – X. couchianus (Sd-couchianus) cross: In this
cross, instead of X. helleri being used as the backcross parent as in (A), a platyﬁsh species, X. couchianus is used. Even though it can be
demonstrated genetically that one-half of the backcross progeny inherit the sex-linked Sd locus, there is suppression of the expression of this
pigment pattern locus in both the F1 and backcross hybrids. (C) Spotted dorsal – X. andersi (Sd-andersi) cross: In this cross, X. maculatus Jp
163 A and the platyﬁsh species X. andersi are used. There is overexpression of the Sd pigment pattern in F1 hybrids, and a wide range of
pigmentation phenotypes is observed among pigmented backcross hybrids. Pigmentation enhancement in hybrids is non-Diff regulated in this
cross (Vielkind et al., 1989). (D) Spotted side – X. helleri (Sp-helleri) UV-inducible melanoma model: This cross is the same as in (A), except X.
maculatus Jp 163 B, carrying the spotted side (Sp) pigment pattern locus, is used. Melanomas can be induced by UV in both the heavy and
light classes (see Nairn et al., 1996b; Setlow et al., 1989; and text). (E) Spotted side – X. couchianus (Sp-couchianus) UV-inducible melanoma
model: In this cross, X. maculatus Jp 163 B is mated to X. couchianus, as for the cross shown in (B). Instead of suppression of pigment
pattern expression, there is dramatic enhancement of the spotted side pigment pattern in F1 hybrids. F1 hybrids are then crossed back to X.
couchianus, and the Sp-inheriting backcross hybrids exhibit heavy and light pigmentation phenotypes as shown. Melanomas have been
reported to be induced in both classes by UVB and UVA wavelengths (Setlow et al., 1993). (F) Spotted side – X. andersi (Sp-andersi) hybrid
cross: In this cross, X. maculatus Jp 163 B is mated to X. andersi and F1 hybrids are crossed back to X. andersi, as in (C). These animals
exhibit a wide range of light and heavy pigmentation phenotypes among Sp-inheriting backcross progeny, and pigment pattern enhancement
and spontaneous melanoma susceptibility are non-Diff controlled, as for the cross shown in (C). BC1 hybrids are refractory to UVB induction
of melanomas (see text). Used with permission.
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schemes. Of particular interest is comparison of panels
B and E, showing that the Sp phenotype is extremely
enhanced in F1 and BC1 hybrids in the X. couchianus
hybrid background (panel E), compared to complete
suppression of Sd in the same genetic background
(panel B). It should be noted that X. maculatus strains
Jp 163 A and Jp 163 B derive from a single female
collected from the wild (Rio Jamapa) that exhibited both
Sd and Sp pigment patterns, which were separated
after nine generations of brother-sister matings into
these two pigmented strains (Kallman, 1975). These
two strains are highly inbred (>90 generations of closed
colony matings) and thus are very closely related
genetically.
These observed phenotypes are not easily explained
by the inheritance model of Figure 1(B). A more accom-
modating inheritance model is shown in Figure 1(C), in
which some gene(s) inherited from the recurrent back-
cross parent modify the effects of Xmrk activity in
pigmented BC1 hybrids. This model explains the pig-
mentation phenotypes observed in the Gordon-Kosswig
model and also can explain other phenotypes in which
there is suppression or differing degrees of pigment
pattern enhancement. In addition, it can account for the
different susceptibilities to spontaneous melanoma
formation observed in BC1 hybrids generated from a
variety of genetic crosses. Any highly inbred strain used
as the recurrent backcross parent possesses its own
Diff allele, thus BC1 hybrids homozygous for this allele
would exhibit the most pronounced effect, and Diff
heterozygotes a less pronounced effect, as the result of
modifying the activity of a particular Mdl in the hybrid
genetic background. Other autosomal loci may also play
important roles. For example, macromelanophore pig-
mentation in the crosses shown in Figure 4(C, E) are
not regulated by the LG V Diff gene, but by another,
non-LG V autosomal locus (Vielkind et al., 1989). These
genetic complexities are difﬁcult to reconcile with the
simple oncogene-tumor suppressor gene model in
which R is contributed by the pigmented X. maculatus
parent and lost through backcrossing. The application of
QTL analysis for identifying other genes that may be
involved in melanoma formation and progression in
these models offers an attractive experimental avenue
for further genetic studies of the Xiphophorus mela-
noma models; this approach is discussed in more detail
later in this review.
Pigmented BC1 hybrids from the crosses represented
in Figure 4 also display different melanoma susceptibili-
ties. Except for the Gordon-Kosswig hybrid model
(Figures 1 and 4A), none of the BC1 hybrids shown
exhibit a particularly high incidence of spontaneous
melanoma formation. This characteristic has been
exploited by several investigators to study induced
melanoma in some of these models. Notably, Setlow
and colleagues ﬁrst used the hybrid model shown in
Figure 4(D) (called Sp-helleri to designate the Sp-Mdl
allele backcrossed into the X. helleri genetic back-
ground) to study UVB induction of melanoma, demon-
strating several-fold increased induction of melanoma at
4–6 months after irradiation of 5-day-old fry (Setlow
et al., 1989). Nairn et al. (1996b) later conﬁrmed UVB
induction of melanoma in this model, and performed
genetic analysis showing that induced melanoma
susceptibility in the Sp-helleri model was linked to the
LG V Diff locus, and paralleled the genetics of the
Gordon-Kosswig (i.e., Sd-helleri) cross. Setlow’s group
also used the cross shown in Figure 4(E) (Sp-couchianus)
to investigate the UV wavelength dependence of
melanoma (Setlow et al., 1993). The action spectrum for
melanoma published in this study has signiﬁcantly
contributed to a prolonged controversy over the relative
importance of UVA and UVB wavelengths in inciting
melanoma in the human population (Lund and Timmins,
2007; Mitchell and Nairn, 2006). Studies designed to
resolve this controversy using Xiphophorus and other
experimental melanoma models are currently in progress
(Mitchell et al., 2007).
The direct acting mutagen N-methyl-N-nitrosourea
(MNU) has also been used to induce melanoma in some
of the crosses shown in Figure 4, including Sp-helleri
(panel D) and Sp-andersi (panel F). The frequency of
MNU-induced melanoma in pigmented BC1 hybrids was
higher than for UVB in the Sp-helleri model (Kazianis
et al., 2001) and no association of melanoma suscepti-
bility with the Diff locus was found, in contrast to UVB
induced melanomas in this model (Nairn et al., 1996b).
In the Sp-andersi model, in which pigmentation is non-
Diff regulated (Vielkind et al., 1989), MNU treatment
also induced melanomas in pigmented BC1 hybrids at a
signiﬁcant frequency (29.7%), whereas UVB failed to
induce melanomas above the background incidence
(<3%). These results suggest that there may be differ-
ent mechanisms for melanoma induction by MNU and
UV. A recent study (Rahn et al., 2009) tested the
hypothesis that MNU could be directly inactivating
CDKN2AB by mutation. MNU-induced melanomas from
F1 and BC1 CDKN2AB heterozygotes were excised and
the X. maculatus CDKN2AB alleles from isolated DNA
samples were sequenced. However, no mutations were
found, suggesting that CDKN2AB inactivation was not a
mechanism for MNU-induced melanomagenesis in this
model.
Xiphophorus hybrid melanoma models have thus been
very useful for establishing the importance of RTK sig-
naling pathways in melanoma formation, and providing
experimental models in which genetic components can
be isolated in different hybrids. From the perspective of
comparative pathobiology, although mutationally altered
EGFR is not the primary culprit in human melanoma,
the Xmrk oncogene is upstream from and orchestrates
many of the same signaling cascades known to be
activated in human melanoma (Chin et al., 2006), such
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this pathway in Xiphophorus melanoma was recognized
very early as critical to melanoma causation in this
model; other oncogenic and pro-survival effects of
Xmrk, mediated through STAT5 and other effectors
(e.g., PI3K) also recapitulate some of the MAPK-inde-
pendent pathways important in human melanoma (see
Meierjohann and Schartl, 2006, for discussion of this
point). On the other hand, from genetic analysis the
CDKN2AB homolog appears to be involved as an auto-
somal genetic determinant of melanoma in some of the
Xiphophorus melanoma models, but since it is over-
expressed, CDKN2AB does not appear to play a role in
Xiphophorus melanoma analogous to the CDKN2A⁄ARF
locus in human melanoma. Functional studies have
shown that the two CDKN2AB alleles from X. helleri
and X. maculatus are regulated differently at the tran-
scriptional level, consistent with observations of their
allele-speciﬁc expression in Xiphophorus melanomas
(Kazianis et al., 2000). Studies in ﬁsh and human cell
lines also show that the p13 proteins from the two dif-
ferent species each interact with CDK4⁄6 and inhibit
CDK4⁄6-dependent phosphorylation of pRB, consistent
with a role in regulating the G1⁄S checkpoint (A. Butler
and R.S.N, unpublished). More functional studies will be
necessary to fully clarify the role of CDKN2AB in mela-
noma susceptibility. However, it is possible that other
candidate genes for Diff, as well as other autosomal
genetic determinants of Xiphophorus melanoma, will be
revealed by further genetic analysis. Finally, it should be
noted that investigation of Xiphophorus melanoma mod-
els has contributed signiﬁcantly to the ﬁeld of photo-
carcinogenesis and the role of sunlight in melanoma
causation (Mitchell and Nairn, 2006; Mitchell et al.,
2007; Setlow, 1999; Setlow and Woodhead, 1994).
Resolving some of the controversies surrounding the
issue of the UV wavelength dependence of melanoma
induction will depend on further studies using Xipho-
phorus in addition to other animal melanoma models, as
discussed later in this review.
Transgenic models of melanoma in ﬁsh
Zebraﬁsh as a model for cancer
In the 1960–1970s, George Streisinger had the vision to
generate an experimental model system that could be
as easily maintained and as genetically tractable as the
fruit ﬂy and worm – with the key difference of having a
vertebrate body plan (Grunwald and Eisen, 2002). From
this pioneering work, in the 1980s and 1990s, Danio
rerio, commonly called the zebraﬁsh, emerged as an
important developmental and genetic vertebrate system
(Patton and Zon, 2001). Like other vertebrates, zebraﬁsh
develop benign and malignant cancers, with similar his-
tological, molecular and pathological features to human
cancers (Amatruda et al., 2002). Zebraﬁsh rarely develop
spontaneous cancer, but can develop tumors in almost
all tissue types after water borne treatment with carcin-
ogens (Spitsbergen et al., 2000a,b). Histopathological
analysis indicates that zebraﬁsh tumors share many sali-
ent features with the cancers derived from the analo-
gous tissue in humans (Amatruda and Patton, 2008;
Amatruda et al., 2002; Spitsbergen et al., 2000a,b; Stern
and Zon, 2003). The shared histopathological features
between zebraﬁsh and human cancers are further mir-
rored in their shared molecular features. For example,
the molecular signatures of the progressive stages of
liver neoplasia – from adenoma to carcinoma – are
shared between zebraﬁsh and human liver cancer (Lam
et al., 2006).
Like Xiphophorus, large numbers of zebraﬁsh can be
grown within the laboratory at relatively low cost, and
development from a single-cell embryo to adulthood
takes about 3 months. Importantly, however, unlike
Xiphophorus, zebraﬁsh fertilize their eggs externally, and
hundreds of single-cell embryos can be collected each
week from a pair of ﬁsh. The embryos are transparent,
and key aspects of embryogenesis – from the ﬁrst cell
division to gastrulation cell movements and organogene-
sis to melanocyte pigmentation – can be viewed under
the light microscope. The zebraﬁsh genome is
sequenced, and is only one of three vertebrate species,
including human and mouse, that has comprehensive
coverage of the genome (http://www.ensembl.org/
Danio_rerio/Info/Index; D. Stemple, personal communi-
cation). Importantly, cancer and tumor suppressor genes
are conserved between ﬁsh and people, as are key sig-
naling, DNA damage, apoptosis, and senescence path-
ways (Amatruda and Patton, 2008).
Anticipating the value of such a system for large-scale
genetic screens, as well as cancer genetics, Streisinger
laid the groundwork for genetic screens in the zebraﬁsh
system (Grunwald and Eisen, 2002; Streisinger et al.,
1981). Large-scale genetic screens in zebraﬁsh have
since identiﬁed hundreds of mutations that cause spe-
ciﬁc developmental and adult phenotypes providing an
unprecedented window into vertebrate development.
Some genetic screens have also identiﬁed new path-
ways and known cancer genes that promote or modify
the occurrence of tumorigenesis in the adult zebraﬁsh
(Amatruda and Patton, 2008). For example, identiﬁcation
of mutations in ribosomal genes that promote cancers
has provided novel insights into how heterozygous loss
of ribososomal components promote tumorigenesis
(Amsterdam et al., 2004; Lai et al., 2009; MacInnes
et al., 2008), and how mutations in genes controlling
genome integrity such as Emi1, Separase and B-Myb,
can enhance the rate of cancer formation in carcinogen
treated or cancer prone animals (Rhodes et al., 2009;
Shepard et al., 2005, 2007). More recently, dominant
mutations that promote T-cell malignancies and germ-
cell tumors in adult ﬁsh have been identiﬁed (Frazer
et al., 2009; Neumann et al., 2009). Zebraﬁsh cancer
imaging, stem cell, and cancer treatment strategies are
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et al., 2009; Smith et al., 2010; Spitsbergen, 2007). For
example, germ-cell tumors in the adult male zebraﬁsh,
analogous to human seminomas, are effectively treated
by whole body irradiation (Neumann et al., 2009).
A notable feature of the zebraﬁsh system is the
ability to generate transgenic animals, allowing visuali-
zation of a gene or pathway in the contexts of both
embryonic and cancer development (Figure 5). Many of
the genes that are involved in melanocyte development
are the same genes that are misregulated in melanoma
development (Lin and Fisher, 2007), and enhanced
transgenic technologies allow for accurate and condi-
tional tissue speciﬁc gene expression in the embryo
and adult (Curado et al., 2008; Halpern et al., 2008;
Kawakami, 2007; Kwan et al., 2007; Yoshikawa et al.,
2008). As seen in Figure 5, expression of tissue
speciﬁc promoters in the melanocyte lineage can assist
in visualizing melanocyte progenitors and differentiation
in the living embryo, and have been used to promote
cancer gene expression in speciﬁc tissues. These tools
are important in probing the fundamental link between
development and cancer, and are a unique asset of the
zebraﬁsh system.
BRAF melanoma models in zebraﬁsh
Although the Xiphophorus system makes clear the
important role of genetics in melanoma development, it
does not provide experimental avenues for facile gen-
ome manipulation such as transgenesis, in contrast to
zebraﬁsh and medaka. While the natural occurrence of
melanoma in zebraﬁsh is rare, knowledge gained from
studies of the genetic and environmental Xiphophorus
melanoma models, coupled with the carcinogen and
transgenic induced cancers in zebraﬁsh, led to the use
of zebraﬁsh to directly test the relevance of oncogenic
BRAF in melanoma. BRAF is a serine⁄threonine kinase
that transduces signals from the upstream RAS kinases
to the downstream MEK kinases, as part of the MAP
kinase (RAS-RAF-MEK-ERK) signaling pathway (Gray-
Schopfer et al., 2007). The MAPK pathway is one of the
most frequently activated pathways in cancer, and in
melanoma mutations in RAS or BRAF lead to its
activation. Sequencing efforts led by the Cancer
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Figure 5. Transgenic melanoma models in zebraﬁsh. (A) Injection of the oncogenic BRAF
V600E transgene into the animal pole of the single
cell embryo generates mosaic founder (F0) ﬁsh that express the transgene in some of the melanocytes, generating ectopic ﬁsh-nevi (black
spots). Here, the BRAF oncogene is expressed under the melanocyte speciﬁc mitfa promoter: the mosaic expression pattern of melanocytes
expressing a mitfa-GFP transgene are clearly visible (bright green dots) in the 3-day-old embryo. Some of the mosaic ﬁsh will have the
transgene in their germ-line, and breeding of these ﬁsh generates stable transgenic lines (F1) that express BRAF
V600E in all neural crest-
derived melanocytes. (B) Clear expression of developing neural crest and melanocytes in living embryos (approximately 20 h post-fertilization)
expressing the sox10-GFP transgene, and (C) the mitfa-GFP transgene. (D) A wild type (left) and transgenic HRAS
V12 (right) 10-week-old
zebraﬁsh (about 1 cm in length). The mosaic HRAS
V12 zebraﬁsh expresses oncogenic RAS from the mitfa promoter, and shows both ectopic
nevi behind the eye and melanoma development in the tail region. (E) An adult wild type zebraﬁsh (3–4 cm in length), (F), a F0 mosaic and
(G), a F1 stable zebraﬁsh expressing BRAF
V600E from the mitfa promoter. Note the ectopic black nevi on the mosaic BRAF
V600E ﬁsh,
compared with the expanded top stripe of the stable BRAF
V600E ﬁsh. Images courtesy of James Lister, Jennifer Richardson, Amy Mitchell
and Corina Anastasaki.
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ity of the melanoma cell lines and primary tumor speci-
mens (Davies et al., 2002). Of these mutations, over
80% had a speciﬁc V600E activating mutation; intrigu-
ingly, kinase-impaired BRAF mutations were also identi-
ﬁed, and subsequently shown to be potent activators of
the MAPK pathway (Dhomen and Marais, 2007). Further
analysis of nevi (benign accumulations of melanocytes,
commonly known as moles) revealed that the majority
of nevi also had BRAF mutations, suggesting that BRAF
mutations alone are not sufﬁcient to promote melanoma
(Pollock et al., 2003).
Expression of BRAF
V600E, but not wild-type BRAF,
from the melanocyte speciﬁc mitfa promoter (Dorsky
et al., 2000) caused the development of large ectopic
melanocytic lesions, as seen in Figure 5. External fertiliza-
tion of the zebraﬁsh embryo allows for microinjection of
transgene DNA constructs at the single-cell stage that
will randomly integrate into the genome (Figure 5A).
Transgene integration appears to occur during early
embryogenesis, and the resulting F0 (founder) ﬁsh are
mosaic in expression of the transgenic construct
(Figure 5A, D, F). Histopathological examination of the
BRAF
V600E lesions showed that these were not tumori-
genic, but rather more closely resembled blue nevi, a
darkly pigmented nevus found in human skin; in accor-
dance with the histopathology, these lesions were called
ﬁsh (f)- nevi (Patton and Zon, 2005; Patton et al., 2005).
Genetic crosses of the mosaic BRAF
V600E ﬁsh produced
an F1 generation with stable integration of the BRAF
V600E
transgene (Figure 5G). These ﬁsh do not appear to have
embryonic melanocyte patterning defects, but during
metamorphosis (about 4 weeks of age) develop a distinct
widening of the most dorsal melanocyte stripe. Both the
BRAF
V600E nevi and stable transgenic lines never go on
to develop melanoma. Thus, expression of the activating
mutation BRAF
V600E can promote altered melanocyte
proliferation and patterning, but is not sufﬁcient to
promote melanoma development.
Unlike with mouse genetics, current technologies in
zebraﬁsh do not provide an easy way to engineer site-
speciﬁc changes by homologous recombination. How-
ever, using TILLING (targeting lesions in genomes), and
zinc-ﬁnger nucleases, mutations in genes of interest can
be generated and identiﬁed (Amsterdam and Hopkins,
2006; Ekker, 2008). p53 is the most frequently mutated
gene in human cancer, and zebraﬁsh p53 shares strong
sequence and functional homology with human p53
(Berghmans et al., 2005). Most p53 mutations are in the
DNA binding domain, and sequencing of over 2600 ENU
mutagenized F1 male ﬁsh in the exons that encode the
DNA binding domains identiﬁed mutations that are ortho-
logous to human p53 cancer mutations. One of the DNA
binding domain mutations, p53
M214K, causes loss of the
apoptotic DNA damage response in embryos and causes
peripheral nerve sheath tumors in the adults at about
11 months of age (Berghmans et al., 2005). Although p53
is not a common mutation in melanoma, the p53 pathway
is frequently altered in melanoma (Chin et al., 2006). To
test the role of BRAF
V600E in a ﬁsh with loss of the p53
pathway, BRAF
V600E was expressed in the p53
M214K line.
Nevi developed in the injected ﬁsh, some of which
progressed to melanoma by 4 months of age. The mela-
nomas were highly invasive, showed genome instability,
and could be transplanted to irradiated zebraﬁsh (Patton
et al., 2005). Thus, this was the ﬁrst animal model to
demonstrate the role of BRAF
V600E in nevi, and that at
least one additional genetic mutation is required for mela-
noma formation (Patton and Zon, 2005; Patton et al.,
2005). This model is relevant for mammalian genetics:
recently expression of BRAF
V600E under the endogenous
promoter, speciﬁcally within melanocytes, has been
shown to promote ectopic melanocyte patterning in
mice, and can cooperate with additional genetic
mutations to promote melanoma (Dankort et al., 2009;
Dhomen et al., 2009).
RAS melanoma models in zebraﬁsh
Another important oncogene in melanoma is NRAS, and
mutations in NRAS or BRAF are detected in almost all
human melanoma (Chin et al., 2006; Gray-Schopfer
et al., 2007). NRAS and BRAF mutations are mutually
exclusive, such that they are not both found mutated in
the same cancers, suggesting that activation of either
BRAF or RAS is sufﬁcient for pathological activation of
the MAPK pathway. Approximately one-third of human
primary and metastatic melanomas harbor a RAS muta-
tion, and RAS mutations are found in over half of
congenital nevi, almost exclusively at codon 61 (Papp
et al., 1999). In mice, activating RAS mutations have long
been established as important models for the genetics of
melanoma (Chin et al., 2006), and the NRAS
Q61K muta-
tion can cooperate with INK4A or ß-catenin mutations to
promote melanoma (Ackermann et al., 2005; Delmas
et al., 2007). In zebraﬁsh, expression of NRAS
Q61K in
melanocytes (from the mitfa promoter) promotes
dramatic changes in pigmentation patterning, with heavy
pigmentation in the dorsal skin and scales, disrupting the
characteristic stripe patterning (Dovey et al., 2009). Low-
grade melanomas develop in these ﬁsh at 1-yr of age,
with a dramatic increase in melanoma incidence and
age-of-onset when crossed to the p53 deﬁcient line
(Dovey et al., 2009). Like the BRAF
V600Ep53 melanomas,
the NRAS
Q61K p53 melanomas share histopathological
features with human melanomas. This pathological simi-
larity extends to the molecular pathways: gene set
enrichment analysis (GSEA) of microarrays of RNA
expression shows the molecular pathways are shared
between human and zebraﬁsh melanoma.
HRAS
V12 is a frequent oncogenic mutation in cancers,
and expression in mouse melanocytes has been key to
our understanding of how RAS signaling cooperates
with mutations in the INK4A-RB or ARF-p53 pathways
to promote melanoma (Chin et al., 2006). In zebraﬁsh,
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V12 from the mitfa promoter (Micha-
ilidou et al., 2009), from the kita promoter (Anelli et al.,
2009), or when expressed throughout the ﬁsh at low
levels (Santoriello et al., 2009), reveals the potential for
HRAS
V12 to promote both ectopic melanocytes and
melanoma. In contrast to the BRAF
V600E and NRAS
Q61K
models, HRAS
V12 ﬁsh show ectopic melanocyte
patterns during early embryogenesis that can rapidly
become melanoma within a few weeks of development
(Anelli et al., 2009; Michailidou et al., 2009). As well as
sharing similar histopathology with human melanoma,
the HRAS
V12 melanoma models also appear to share
epigenomic changes to their genome: global mRNA
expression is reduced with the exception of cell cycle
genes, and there are visible changes in histone methyla-
tion (Anelli et al., 2009). RAS has multiple effector path-
ways, including the PTEN-AKT pathway, and the
combined activation of the MAPK and AKT signaling
pathways is one explanation for the potent oncogenic
potential of HRAS
V12. Indeed, dominant-interfering
forms of AKT (PI3K) can prevent the activity of HRAS
V12
in the PTEN-AKT effector pathway, preventing progres-
sion of ectopic melanocytes to melanoma (Michailidou
et al., 2009). Activation of the MAPK pathway coupled
with activation of the AKT signaling pathway is directly
relevant to human melanoma: loss of PTEN is com-
monly associated with activating BRAF mutations in
human melanoma, and genetics in mouse and zebraﬁsh
reveal that PTEN mutations are required for BRAF
V600E
mutations to progress from nevi to melanoma (Dankort
et al., 2009; J. Richardson, J. den Hertog, E.E.P. unpub-
lished data). Activation of the AKT signaling pathway
has also been shown to collaborate with the hedgehog
pathway to promote uveal melanoma in zebraﬁsh (Ju
et al., 2009).
In cancer, RAS and BRAF mutations arise de novo in
somatic tissues, but germ-line RAS, RAF and MEK
mutations have also recently been identiﬁed as causing
a series of syndromes that share overlapping clinical
features. These Cardio-facio-cutaneous (CFC) related
syndromes are characterized by speciﬁc facial character-
istics, heart abnormalities and skin conditions, including
enhanced numbers of nevi (Tidyman and Rauen, 2009).
The CFC-BRAF allele spectrum includes both kinase-
active and kinase-impaired mutant alleles, all of which
appear to act as gain-of-function mutations in vivo, and
are sensitive to small molecule inhibitors (Anastasaki
et al., 2009; Dhomen and Marais, 2007). Both kinase
active and kinase impaired BRAF-CFC alleles promote
early cell movement phenotypes in zebraﬁsh embryonic
gastrulation, and can promote nevi formation in the
adult zebraﬁsh (Anastasaki et al., 2009; C. Anastasaki,
K. Rauen, E.E.P, unpublished data). Mutations in HRAS
underlie Costello syndrome, a developmental syndrome
characterized by short stature, cancer susceptibility, and
heart and mental deﬁciencies (Tidyman and Rauen,
2009). In zebraﬁsh, ubiquitous expression of low levels
of HRAS
V12 produce adult ﬁsh that share characteristics
with Costello syndrome, develop melanoma and other
cancers, and express the hallmarks of senescence in
the heart and brain (Santoriello et al., 2009). One possi-
bility is that tissue speciﬁc thresholds to activated RAS,
BRAF or MEK expression may underlie differing cellular
outcomes, including cell proliferation in melanocytes,
movement in early development, and senescence in
heart and brain development.
The particular mutation, copy number and tissue
speciﬁc expression each contribute to the etiology of
developmental disease and cancer, including melanoma
(Chin et al., 2006; Crowson et al., 2007; Miller and
Mihm, 2006). A technical aspect of the transgenic work
that is under considerable attention from the zebraﬁsh
community is that integrated transgenes are often at
variable copy number, and this can inﬂuence the physi-
cal, cellular and molecular phenotype (Dovey et al.,
2009). While the pathology of zebraﬁsh melanoma is
relevant to our understanding of human melanoma,
new technologies that allow for expression of engi-
neered mutations from the endogenous promoter, as
attainable in mice (Dankort et al., 2009; Dhomen et al.,
2009), is important to align zebraﬁsh melanoma mod-
els, and models of other diseases, with the analogous
human condition.
A new Xmrk-medaka melanoma model
As discussed in previous sections, elucidation of the
role of Xmrk as a potent oncogene in Xiphophorus mela-
noma ﬁrst established an avenue to investigate the
genetic basis of this disease in an experimental animal
model. However, Xiphophorus is a live-bearing ﬁsh, and
not amenable to the manipulation of embryos required
for such approaches as transgenesis. Circumventing this
problem, Schartl and colleagues exploited the ease of
using the medaka ﬁsh (Oryzias latipes) as a genetic
model (Schartl et al., 2010). Like zebraﬁsh, medaka is
amenable to transgenesis, TILLING, and other sophisti-
cated genetic approaches, and can be accommodated in
the laboratory setting. The embryos develop ex utero,
are transparent, and many of the promoters are inter-
changeable between zebraﬁsh and medaka. The gen-
ome is sequenced, and like zebraﬁsh, many of the
cancer genes and pathways are highly similar to other
vertebrates, including humans. Expression of Xmrk
under the mitf promoter resulted in potent melanoma
and pigment cell development in melanocytes, as well
as other pigment cell types (Schartl et al., 2010). The
Xmrk-medaka melanomas are highly invasive into the
internal organs and spinal cord, and appear metastatic.
As often occurs in human melanoma, the more aggres-
sive melanomas contained melanocytes that are often
less pigmented and differentiated, compared with mela-
nocytes in the wild type medaka. Melanoma progres-
sion was strongly dependent on Xmrk dosage: the
hemizygous ﬁsh developed extended dark black spots
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these pigmented lesions went on to develop into mela-
noma by 3 months. In contrast, medaka homozygous
for the Xmrk transgene developed pigmentation
changes by 8–10 days post-fertilization that became
cancerous within 2–6 weeks with almost complete pen-
etrance (Schartl et al., 2010). Downstream signaling of
Xmrk has been well studied, and a good understanding
of the role of MAPK signaling, PI3 kinase, PLC-gamma,
STAT5, FYN and FAK signaling has begun to emerge, as
previously discussed. The Xmrk-medaka melanoma
show activation of the AKT signaling pathway, as well
as strong activation of the STAT5 signaling pathway and
enhanced MITF protein. As with the HRAS
V12 zebraﬁsh
melanoma models, the potential for Xmrk to induce mel-
anoma without cooperating mutations may reﬂect the
upstream signaling potential of RAS to affect a wider
series of downstream targets (Schartl et al., 2010). After
years of genetics and cell biology, this work deﬁnitely
demonstrates that Xmrk is a highly potent oncogene
in vivo.
Swimming forward: ﬁsh as unique tools
for melanoma research
With the impressive range of genetic and transgenic
models of melanoma progression in three different spe-
cies of ﬁsh, where do we go from here? The unique
genetic crosses available in the Xiphophorus system
provide an opportunity to explore how complex genetic
traits, pigmentation and exposure to UV light contribute
to melanoma progression, and how pigmentation pat-
terning and oncogenic mutations can be under complex
genetic or epigenetic control and sexual selection in the
wild. The zebraﬁsh and medaka systems provide the
foundation for genetic screening for germ-line variants
that inﬂuence melanoma pathology, as well as for func-
tional genomic approaches that explore the wealth of
the human melanoma genomic data (Greenman et al.,
2007; Pleasance et al., 2010). Transparent zebraﬁsh and
medaka – used in genetic, transgenic and transplanta-
tion approaches – provide unparalleled model systems
to observe melanocyte and melanoma biology in vivo.
Finally, small molecule screening in zebraﬁsh is driving
forward a unique and clinically relevant whole-animal
screening approach that is identifying novel and known
molecules that affect melanocyte and melanoma bio-
logy. Here, we describe some of innovative approaches
that are being used to gain new insight into melanoma
biology using these distinctive ﬁsh models.
UV light, photocarcinogenesis and melanoma
Sunlight exposure is a critical risk factor for melanoma,
and unresolved questions include how gene-environ-
ment interactions contribute to nevi and melanoma
development, and the UV wavelength dependence of
melanoma induction. A recent review (von Thaler et al.,
2010) on the relative roles of different wavelengths of
UV light in the solar spectrum in inciting melanoma
highlights the controversy over whether UVA contrib-
utes directly to melanoma causation. Experimental
results collected using two Xiphophorus hybrid mela-
noma models have been central to this debate, the
Sp-helleri hybrid cross (Figure 4B) and the Sp-couchi-
anus cross (Figure 4E). Setlow originally used the Sp-
helleri hybrid melanoma model to demonstrate that
UVB irradiation of fry induced melanoma to a signiﬁcant
degree above background incidence (Setlow et al.,
1989). This result was conﬁrmed by Nairn et al. (1996b),
who also showed that UVB melanoma susceptibility
was linked to the Diff locus. Setlow and colleagues also
used the Sp-couchianus model to investigate the wave-
length dependence of melanoma induction and reported
results indicating that UVA wavelengths were as effec-
tive as UVB wavelengths in inducing melanoma (Setlow
et al., 1993). UVA is quantitatively more prevalent than
UVB ( 10-fold) in sunlight incident to the earth’s sur-
face, and Setlow proposed that UVA was therefore
more responsible than UVB for inciting melanoma in the
human population (Setlow and Woodhead, 1994; Setlow
et al., 1993). This assertion was, and remains, highly
controversial, since this result has not been replicated in
other animal melanoma models studied, as discussed in
several recent reviews (Bennett, 2008; Lund and Tim-
mins, 2007; Noonan et al., 2003). In support of the UVA
induction hypothesis a study was recently published
using the same Sp-couchianus model to investigate pho-
tosensitization of melanin as a possible mechanism for
melanoma formation (Wood et al., 2006). Electron para-
magnetic resonance was used to monitor UV induction
of reactive melanin radicals in pigmented skin. The
action spectrum for melanin-sensitized generation of
reactive radicals approximately tracked the action spec-
trum for melanoma formation reported by Setlow et al.
(1993), consistent with a role for UVA in melanoma
causation through a free radical mechanism, requiring
the presence of melanin. However, a very recent study
(D.L.M, A. Fernandez, R.S.N., R. Garcia, L. Panniker, D.
Trono, H. Thames, I. Gimenez-Conti, submitted) attem-
pted to reproduce Setlow’s melanoma induction results
using larger numbers of Sp-couchianus BC1 hybrids and
concluded that UVA did not induce melanomas above
the background incidence in this model, but that UVB
was effective. Also, UVA fails to induce melanoma in
BC1 hybrids from the original UVB-inducible Sp-helleri
model (R.S.N, unpublished results). These results are
consistent with mouse studies in which UVB, but not
UVA, induced melanoma (De Fabo et al., 2004). How-
ever, this controversy is likely to continue, especially
since suntanning beds have widespread use in Europe
and North America, and advertise their ‘safety’ on the
basis of emitting predominantly UVA light. Investigation
in the future of UV inducibility of melanoma in other
Xiphophorus crosses, and the transgenic models
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signiﬁcant role in resolving this issue.
In fact, the wealth of experience in UV-induced mela-
noma protocols developed by the Xiphophorus commu-
nity is now being translated to the zebraﬁsh system
(Zeng et al., 2009). As in mammalian cells, the UV DNA
damage response involves p53, and the p53
M214K
genetic line fails to initiate an apoptotic-DNA damage
response after UV treatment (Zeng et al., 2009) Interest-
ingly, it appears that the UV damage response may be
developmentally regulated in zebraﬁsh embryos (Dong
et al., 2007; Zeng et al., 2009). However, less work has
been done on the effects of UV light on adult zebraﬁsh,
and studies that are analogous to human environmental
UV exposure conditions will be important. Recently,
exposure of adult zebraﬁsh skin to UV light has been
shown to activate a phospho-H2AX DNA damage
response, and p53 deﬁcient zebraﬁsh have a decreased
ability to promote repair of UV induced DNA damage in
their skin (Zeng et al., 2009). Early UV treatment results
of genetic and transgenic cancer prone lines suggest
that some zebraﬁsh genetic backgrounds may be sensi-
tive to melanocyte changes after UV treatment (Z. Zeng,
D.L.M., E.E.P., unpublished data).
Gene modiﬁers of melanoma progression
Many heritable traits are polygenic, and while studies of
Xiphophorus melanoma have revealed strong genetic
determinants of melanoma susceptibility, other genes
having more modest effects are likely also to be
involved in modulating the melanoma susceptibility phe-
notype. The existence of several Xiphophorus backcross
hybrid melanoma models exhibiting different melanoma
susceptibilities, as discussed (see Figure 4), offers a
unique opportunity to apply quantitative trait linkage
(QTL) analysis to identify additional genes that modify
melanoma formation and progression. The underlying
basis of using genetic markers to detect QTL is genetic
linkage; there tends to be less meiotic recombination
between regions of a chromosome that lie close to one
another than for those lying far apart. Thus, alleles at a
polymorphic marker locus and a polymorphic QTL that
lies close to it will tend to segregate together at meio-
sis. The closer together a QTL and ﬂanking marker are,
the tighter this intergenerational association will be.
Since Xiphophorus melanoma models are generated
through interspecies hybridization, F1 hybrids have
highly elevated heterozygosity throughout the genome,
and backcross progeny exhibit a wide range of multi-
locus genotypes not found in either parental species. In
primary segregating populations generated from genetic
backcrossing (i.e., BC1 hybrids) the association of spe-
ciﬁc marker-locus alleles and QTL alleles derives directly
from the haplotypes of the parental species. Thus the
underlying basis for mapping QTLs for complex traits in
this situation is to detect a correlation between marker
allele and phenotypic state of the complex trait. This is
conceptually similar to seeking direct associations
between allelic variants and phenotypic states in
genome-wide association studies. Speciﬁcally, In BC1
hybrids, representing only a single generation of meiotic
recombination, residual linkage disequilibrium between a
QTL and a marker locus will reﬂect the genetic distance
between them. Interspeciﬁc hybridization and back-
crossing thus provide a powerful strategy to construct
genetic linkage maps with dense coverage and to iden-
tify chromosomal regions that harbor QTLs that inﬂu-
ence physical and physiological phenotypes – including
melanoma susceptibility. The recent availability of
sophisticated genetic resources for Xiphophorus, such
as BAC libraries (e.g., Froschauer et al., 2002; Walter
et al., 2006), further enhances the strength of this
approach. The Xiphophorus hybrid melanoma models
are therefore ideally suited to the application of QTL
analysis for revealing genes that may individually exert
modest effects on melanoma susceptibility and⁄or pro-
gression. This general approach can also be extended to
other genes that may be important in melanoma, such
as DNA repair genes, in Xiphophorus models (Mitchell
et al., 2007).
In the zebraﬁsh melanoma models, testing the func-
tion of new and known genes that collaborate with
BRAF to promote melanoma progression and invasion is
an important next step. Len Zon and colleagues are
screening melanoma relevant genes for enhanced mela-
noma progression in the BRAF
V600Ep53 model, which
will provide insight into novel melanoma progression
pathways (L. Zon, personal communication). Direct test-
ing of additional genetic lines of the PTEN pathway and
the MITF pathway is also underway, revealing new
understanding of how cooperating mutations collaborate
with BRAF
V600E in melanoma development and patho-
logy (J. Richardson, J. den Hertog, J. Lister, E.E.P.,
unpublished data). One the most important aspects of
the Xmrk-medaka model is the identiﬁcation of genetic
modiﬁers of pigment cell tumor incidence, pathology
and tumor spectrum (Schartl et al., 2010). While labora-
tory ﬁsh are not clones, very often lines of ﬁsh are
maintained that are derived from a small founder popu-
lation. In the HB32C background, Xmrk expression pri-
marily causes highly invasive melanomas. In contrast, in
the Carbio background, a non-inbred line and of mixed
genetic background, Xmrk expressing ﬁsh rarely develop
melanoma, and instead develop almost exclusively exo-
phytic xanthoerythrophoromas (tumors in the yellow
and red pigment cells), that break into the underlying
musculature only at the terminal stages. With the loss
of p53 in the Carbio background, the tumor spectrum in
the Xmrk-medaka ﬁsh changes, with development
of fast growing nodular melanomas. Finally, in the albino
(i-3) background, weakly pigmented melanomas develop
in about a third of the ﬁsh, while almost half of the ﬁsh
develop uveal melanomas. These studies demonstrate
the ability of genetic context and background to shape
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framework for future genetic screens and crosses to
identify genetic modiﬁers of melanoma pathology.
Melanoma and the microenvironment
While intensive efforts are concentrated on understand-
ing the genetic and epigenetic conditions that cause a
melanocyte to transform to melanoma, recent work by
the Hendrix laboratory and others has developed the
zebraﬁsh as a ‘biosensor’ to explore the bidirectional
signaling of melanoma cells within the environment of
the whole embryo (Hendrix et al., 2007; Topczewska
et al., 2006). Aggressive melanoma cells are highly
motile and adopt characteristics of de-differentiated,
multipotent neural crest progenitors that can respond to
and inﬂuence cells in their environment (Hendrix et al.,
2007). This plasticity is also a characteristic of embry-
onic stem cells: in the developing embryo neural crest
cells give rise to multiple cell types that actively migrate
and invade embryonic tissues to arrive at the skin and
fully differentiate into melanocytes (White and Zon,
2008). The microenvironment plays an important role in
promoting the behavior and fate of both embryonic
stem cells and melanoma cancer cells, and understand-
ing the cellular communication between cells and their
environment is at the intersection of both developmen-
tal and cancer biology (Kasemeier-Kulesa et al., 2008).
As zebraﬁsh embryos are transparent, and develop
externally, ﬂuorescently labeled human cancer cell lines
can be injected into the embryo and assessed for inﬂu-
ence of the environment on the melanoma cells, and
vice versa (Hendrix et al., 2007). By injection of mela-
noma cancer cell lines with varying degrees of meta-
static potential into the zebraﬁsh embryo, Mary Hendrix
and colleagues identiﬁed an aggressive melanoma can-
cer line that could inﬂuence the development of the sur-
rounding embryonic cells (Topczewska et al., 2006).
Injection of melanoma cells into the animal pole of the
early developing embryo (blastula-stage, at 3hpf)
induced the zebraﬁsh embryo to develop an ectopic
cranial outgrowth. Similarly, injection of the cells into
the margin of the blastula induces the formation of a
secondary axis. Interestingly, some of the melanoma
cells injected into later stage embryos also appear to be
able to be reprogrammed by their environment; while
human melanoma cells can survive in the adult zebra-
ﬁsh, their cancerous phenotypes are suppressed (Lee
et al., 2005). The axis reorganizing activity of the
metastatic melanoma cells was identiﬁed as the mor-
phogen, Nodal. In culture, reduction of Nodal activity
restores the differentiated melanocyte phenotype (e.g.,
expression of tyrosinase), while eliminating the trans-
differentiated phenotype. Thus, Nodal is a novel
melanoma-dependent pathway that both shapes the
embryonic surrounding and maintains melanoma plastic-
ity. Importantly, inhibition of Nodal causes a reduction
of tumorigenicity in the mouse, and has been accurately
identiﬁed as a prognostic biomarker for melanoma
(Strizzi et al., 2009). Nodal had not previously been
implicated in melanoma progression, and the use of
zebraﬁsh as a ‘biosensor’ has successfully identiﬁed
Nodal as a key signaling pathway for melanoma, and a
potential therapeutic target.
Zebraﬁsh and medaka are also being used as a xeno-
graft models to study cancer cell proliferation, migration,
and angiogenesis (Hasegawa et al., 2009; Nicoli and
Presta, 2007; Stoletov and Klemke, 2008). As xenograft
models, ﬁsh have the advantages of unprecedented
imaging quality and are highly amenable to cost-effec-
tive pharmacological testing (Hasegawa et al., 2009;
Stoletov and Klemke, 2008; Stoletov et al., 2007).
Human melanoma cells injected into 2-day-old zebraﬁsh
embryos can survive, proliferate, migrate, form tumor-
like masses and induce a robust angiogenic response
(Haldi et al., 2006; Nicoli et al., 2007, 2008). Human can-
cer cells can also be injected later in development (e.g.,
30 days), and while the immune system must be chemi-
cally suppressed, the organs and vascular system are
already developed, uncoupling the effects of develop-
ment on the xenograft (Stoletov and Klemke, 2008;
Stoletov et al., 2007). In medaka, inbred lines allow for
transplantation of syngeneic melanoma cancer cell lines
into the adult host without irradiation, allowing for the
following of in vivo imaging of cancer cells at all stages
of development (Hasegawa et al., 2009). The dynamic
interactions between cancer cells and host tissues have
been captured using confocal microscopy on transgenic
zebraﬁsh expressing GFP in the vasculature, enabling
exceptional intravital imaging of labeled cancer cells
invading and remodeling the host vasculature (Stoletov
et al., 2007). Importantly, gene knockdown, genetic
engineering technologies, and direct injection of proteins
and chemicals can modify both the zebraﬁsh host
and⁄or the cancer cells (Nicoli and Presta, 2007; Stole-
tov and Klemke, 2008). For example, B16 human mela-
noma cells injected into a 2-day-old zebraﬁsh embryo
can promote a robust angiogenic response in the zebra-
ﬁsh that can be reduced by exposure to chemical inhibi-
tors of FGF and VEGF receptors. Similarly, knockdown
of the cell-cell adhesion molecule, VE-cadherin, in the
zebraﬁsh embryo can prevent tumor-induced angiogene-
sis without altering normal vessel development (Nicoli
et al., 2007).
While zebraﬁsh and medaka early embryos are trans-
parent, the pigment of juvenile and adult ﬁsh obscure
internally labeled cells. New transparent medaka and ze-
braﬁsh provide a unique window into the development
of tissues during development and during adulthood
(Figure 6). For example, in medaka, GFP reporter
expression in the germline allows for visualization of the
developing testis and ovary from embryogenesis to
adulthood, and the detailed and continued maturation of
the ovary after spawning in the adult (Wakamatsu et al.,
2001). In zebraﬁsh, Zon and colleagues have also
Patton et al.
330 ª 2010 John Wiley & Sons A/Srecently generated a transparent adult zebraﬁsh named
Casper that lacks body pigment cells through mutation
of mitf, and an as of yet unidentiﬁed mutation roy
(White et al., 2008). This transparent ﬁsh allows for the
impressive visualization of labeled transplanted cells,
such as GFP-labeled marrow cells after irradiation abla-
tion of the hematopoietic cells, or the growth and
metastasis of pigmented melanoma cells (Figure 6). The
naturally transparent embryo and the adult ﬁsh provide
unique resources for the study of both engrafted and
endogenous melanoma cell characteristics, stem cells
and microenvironment interactions in a living animal.
Small molecule screening in ﬁsh
The small size of the developing zebraﬁsh and medaka
makes them ideal organisms to study the effects of
small molecules on melanocyte development and mela-
noma models. The fundamental link between develop-
ment and cancer means that small molecules that alter
melanocyte biology and regeneration may be relevant to
our understanding of melanoma development (White
and Zon, 2008). We and others have performed small
molecule screens, and have identiﬁed chemical com-
pounds that interfere with speciﬁc aspects of melano-
cyte biology, including melanocyte development,
migration, pigmentation, and survival (O’Reilly-Pol and
Johnson, 2009; White and Zon, 2008; H. Ishizaki, R.
Kelsh, E.E.P., unpublished data). In the developing
zebraﬁsh, melanocytes become visible by approximately
28 h post-fertilization (Kelsh et al., 2009), and ﬂuores-
cent reporter lines allow for neural crest progenitors and
unpigmented melanocytes to be visualized in the living
embryo (Figure 5). Multiple embryos can easily be
arrayed into each well of a 96-well plate in about 300 ll
of embryo water containing speciﬁc chemicals, as
shown in Figure 6(E) (Kaufman et al., 2009). The high
fecundity of the zebraﬁsh allows for hundreds to thou-
sands of chemicals to be screened each week in an
academic laboratory.
Stephen Johnson and colleagues have used small
molecules to temporally control melanocyte cell death,
and through chemical and genetic screens have
identiﬁed compounds that control the recruitment and
development of a melanocyte stem cell population
(O’Reilly-Pol and Johnson, 2009; White and Zon, 2008).
Chemical control of these cell types and of the path-
ways that modulate their development complement the
genetic mutants that alter melanocyte biology, and pro-
vide novel hypotheses to test which cell types and path-
ways contribute to melanocyte and melanoma
development. The identiﬁed chemicals may also be valu-
able drug-like leads: screening of clinically approved
drugs on zebraﬁsh embryos has identiﬁed prostagalan-
din as an important regulator of hematopoietic stem
cells in embryonic and adult ﬁsh and in mice, and is cur-
rently in clinical trial for enhancing hematopoietic stem
engraftment after marrow depletion (North et al., 2007;
L. Zon, personal communication). Treating ﬁsh with
small molecules is not limited to the embryonic stages:
adult ﬁsh can be directly immersed in chemical treat-
ment water, or through chemical injection into the retro-
orbital of the eye (Pugach et al., 2009). Small molecules
are also being screened on embryos that have been
transplanted with ﬂuorescent human cancer cells to
C E A
D B
Figure 6. Creative approaches to studying melanocytes and melanoma in ﬁsh. Genetic modiﬁers can alter pigment cell tumor spectrum in
the Xmrk medaka model: (A) Xmrk in the Carbio line promotes exophytic yellow and red cell tumors, but (B) with the loss of p53 in the Carbio
line there is a dramatic shift in the tumor spectrum, and the ﬁsh succumb to endophytic, highly invasive melanoma. In (C) deRed labeled
human melanoma cells are clearly visible at the yolk sac (arrow, top ﬁsh) of an 8-day-old zebraﬁsh embryo. The vasculature is highly visible
through expression of the ﬂi1-GFP transgene. An invasive melanoma cell line begins to invade the developing intestinal bulb and circulates in
the blood vasculature (arrows; bottom ﬁsh). (D) The Casper zebraﬁsh lacks body pigment: darkly pigmented transplanted melanoma cells can
be clearly seen in the internal body of the zebraﬁsh. (E) Two-day-old zebraﬁsh embryos, still in their chorion (permeable shell) are arrayed in
the wells of a 96-well plate. Each well contains a small molecule dissolved in 300 ll of ﬁsh-water: the embryos in well C3 (left) are not
affected by the compound in the well, and have the normal melanocyte pigmentation pattern, while the compound in well C4 (right) prevents
normal melanocyte pigmentation and the embryos are white. Images by Manfred Schartl, Shuning He, Ewa Snaar-Jagalska, Richard White,
Len Zon, and E.E.P.
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ª 2010 John Wiley & Sons A/S 331modulate proliferation, migration and angiogenesis, as
discussed above (Figure 6C). These studies hold prom-
ise for identifying new and targetable pathways in mela-
nocyte development and melanoma, and also
microenvironment pathways that might directly alter
melanoma progression.
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